Asymmetric Allylation and Reduction of Imines
FULL PAPER
30.36, 22.85, 20.53 ppm. IR (KBr): ν = 3297, 3257, 3106, 3070,
2350, 2167, 1961, 1896, 1823, 1681, 1574, 1495, 1448, 1424, 1385,
1353, 1306, 1284, 1270, 1242, 1230, 1182, 1144, 1101, 1090, 1077,
˜
2978, 2933, 2878, 1666, 1597, 1571, 1552, 1508, 1448, 1416, 1383,
1336, 1310, 1286, 1250, 1197, 1116, 978, 921, 805, 781, 448 cm–1. 1024, 1017, 974, 956, 924, 900, 874, 841, 802, 761, 749, 738, 700,
MS (ESI+): m/z = 319.2 [M + Na]+, 614.9 [2M + Na]+.
C18H20N2O2 (296.36): calcd. C 72.95, H 6.80, N 9.45; found C
73.12, H 7.06, N 9.24.
628, 611, 544, 525, 480, 428 cm–1. MS (ESI+): m/z = 269.2 [M +
Na]+, 514.8 [2M + Na]+. C14H18N2O2 (246.30): calcd. C 68.27, H
7.37, N 11.37; found C 68.16, H 7.45, N 11.30.
Compound 6: This compound was prepared from N-formyl--pro-
line and (R)-phenylethylamine by the same procedure as described
above for 2 to give 6 as a white solid in 85% yield. [α]2D0 = –100.2
Compound 3: This compound was prepared from N-formyl--pro-
line and (S)-1-(1-naphthyl)ethylamine in a manner analogous to 2
and was obtained as a white solid. [α]2D0 = +155.0 (c = 0.5, CHCl3).
1H NMR (300 MHz, CDCl3, cis and trans forms): δ = 8.19 and
8.14(2ϫs, 1 H, CHO), 8.02–7.94 (m, 1 H), 7.86–7.70 (m, 2 H),
7.54–7.38 (m, 4 H), 6.35 (d, J = 8.4 Hz, 1 H, NH), 5.90 and 5.80
(2ϫquintet, J = 7.5 and 7.2 Hz, 1 H), 4.54 and 4.30 (2ϫdd, J =
6.9 and 3.6 Hz; J = 8.1 and 3.3 Hz, 1 H), 3.52–3.31 (m, 2 H), 2.55–
2.43 and 2.22–2.04 (m, 1 H), 2.02–1.71 (m, 3 H), 1.64 and 1.60
(2ϫd, J = 6.9 Hz, 3 H, Me) ppm. 13C NMR (75.5 MHz, CDCl3,
major isomer): δ = 169.11, 162.27, 138.81, 133.81, 130.73, 128.74,
127.91, 126.10, 125.60, 125.34, 123.13, 122.28, 57.90, 46.74, 45.15,
26.90, 24.02, 21.57 ppm. 13C NMR (75.5 MHz, CDCl3, minor iso-
mer): δ = 170.15, 162.17, 137.28, 133.89, 130.98, 128.90, 128.64,
126.53, 125.93, 125.15, 122.94, 122.70, 60.89, 44.72, 44.17, 30.34,
1
(c = 1, CHCl3). H NMR (300 MHz, CDCl3, cis and trans forms):
δ = 8.29 and 8.26(2ϫs, 1 H, CHO), 7.45 and 6.15 (2ϫd, J = 7.2
and 8.7 Hz, 1 H, NH), 7.36–7.16 (m, 5 H), 5.12 and 5.02 (2ϫquin-
tets, J = 7.2 Hz, 1 H), 4.53 and 4.35 (2ϫdd, J = 6.9 and 4.2 Hz
and J = 7.5 and 3.9 Hz, 1 H), 3.61–3.38 (m, 2 H), 2.53–2.47 and
2.20–2.12 (m, 1 H), 2.06–1.76 (m, 3 H), 1.48 and 1.45 (2ϫd, J =
7.2 Hz, 3 H, Me) ppm. 13C NMR (75.5 MHz, CDCl3, major iso-
mer): δ = 169.21, 162.09, 143.30, 128.34, 126.82, 125.66, 57.69,
48.88, 46.71, 26.90, 23.92, 22.41 ppm. 13C NMR (75.5 MHz,
CDCl3, minor isomer): δ = 170.38, 161.95, 142.83, 128.45, 127.15,
125.79, 60.51, 48.63, 44.10, 30.23, 22.69, 21.39 ppm. IR (KBr): ν =
˜
3293, 3061, 2978, 2969, 2927, 2885, 2866, 1681, 1638, 1547, 1496,
1463, 1448, 1424, 1386, 1306, 1270, 1230, 1182, 1143, 1100, 1098,
1017, 974, 924, 900, 875, 841, 801, 760, 738, 699, 627, 611, 545,
525, 480, 426 cm–1. MS (ESI+): m/z = 247.0 [M + H]+, 269.1 [M
+ Na]+, 514.8 [2M + Na]+. C14H18N2O2 (246.30): calcd. C 68.27,
H 7.37, N 11.37; found C 67.94, H 7.65, N 11.15.
22.65, 20.21 ppm. IR (KBr): ν = 3288, 3051, 2976, 2875, 1657,
˜
1535, 1448, 1379, 1238, 1182, 1043, 802, 779, 443 cm–1. MS (ESI+):
m/z = 319.2 [M + Na]+, 614.9 [2M + Na]+. C18H20N2O2 (296.36):
calcd. C 72.95, H 6.80, N 9.45; found C 72.80, H 6.52, N 9.22.
Compound 4: This compound was prepared from N-formyl--pro-
line and (R)-phenylethylamine by the same procedure as described
above for 2 to give 4 as a white solid in 88% yield. [α]2D0 = +194.5
Compound 7: This compound was prepared from (R)-1-(1-naph-
thyl)ethylamine and -proline by the same procedures as described
in the literature for its derivative.[2i] The crude material was purified
by flash chromatography on silica gel (CH2Cl2/MeOH, 95:5) to give
pure 7 as a white solid (478 mg, 70% yield). [α]2D0 = –34.0 (c =
1.152, CHCl3). 1H NMR (600 MHz, CDCl3): δ = 11.79 (d, J =
9.0 Hz, 1 H, NH), 8.07 (d, J = 7.8 Hz, 1 H), 7.81 (d, J = 8.4 Hz, 1
H), 7.71 (d, J = 8.4 Hz, 1 H), 7.50 (d, J = 7.2 Hz, 1 H), 7.49–7.46
(m, 1 H), 7.44–7.39 (m, 2 H), 5.89 (quintet, J = 7.2 Hz, 1 H), 3.65
(br. s, 1 H), 3.37–3.33 (m, 1 H), 3.22–3.17 (m, 1 H), 3.11 (m, 1 H),
2.36–2.23 (m, 4 H), 2.11–2.09 (m, 1 H), 1.91–1.88 (m, 2 H), 1.84–
1.79 (m, 1 H), 1.68–1.59 (m, 3 H), 1.61 (d, J = 7.2 Hz, 3 H), 1.31–
1.23 (m, 2 H), 1.18–1.11 (m, 1 H) ppm. 13C NMR (75.5 MHz,
CDCl3): δ = 167.92, 139.12, 133.82, 130.74, 128.71, 127.65, 126.00,
125.45, 125.43, 123.27, 122.54, 76.23, 72.59, 66.51, 44.22, 28.39,
27.61, 27.48, 25.38, 25.26, 24.97, 21.66, 20.06 ppm. MS (ESI+):
m/z = 367.3 [M + H]+, 389.3 [M + Na]+, 733.1 [2M + H]+, 755.2
[2M + Na]+. HRMS (ESI): calcd. for C23H30N2O2 [M + H]+
367.23800; found 367.23798. C23H30N2O2 (366.50): calcd. C 75.37,
H 8.25, N 7.64; found C 75.67, H 8.08, N 7.40.
1
(c = 1, EtOH). H NMR (300 MHz, CDCl3, cis and trans forms):
δ = 8.31 and 8.22(2ϫs, 1 H, CHO), 7.41 and 6.18 (2ϫd, J =
6.6 Hz, 1 H, NH), 7.38–7.19 (m, 5 H), 5.11 and 5.00 (2ϫquintets,
J = 7.5 and 7.1 Hz, 1 H), 4.46 and 4.32 (2ϫdd, J = 8.1 and 3.9 Hz,
1 H), 3.62–3.46 (m, 2 H), 2.52–2.41 and 2.23–2.17 (m, 1 H), 2.08–
1.76 (m, 3 H), 1.47 and 1.42 (2ϫd, J = 6.3 and 7.2 Hz, 3 H, Me)
ppm. 13C NMR (75.5 MHz, CDCl3, major isomer): δ = 169.32,
162.15, 143.30, 128.45, 127.01, 125.90, 57.78, 49.02, 46.85, 27.00,
24.04, 22.09 ppm. 13C NMR (75.5 MHz, CDCl3, minor isomer): δ
= 170.40, 162.07, 142.62, 128.54, 127.30, 126.00, 60.61, 48.63,
44.25, 30.27, 22.78, 21.31 ppm. IR (KBr): ν = 3296, 3065, 2969,
˜
2946, 2925, 2889, 2870, 2783, 2657, 2600, 2468, 2339, 2166, 2048,
1963, 1897, 1882, 1823, 1602, 1493, 1474, 1463, 1353, 1305, 1284,
1268, 1210, 1145, 1134, 1099, 1091, 1075, 1030, 1014, 976, 954,
923, 912, 900, 874, 842, 736, 648 cm–1. MS (ESI+): m/z = 247.0 [M
+ H]+, 269.1 [M + Na]+, 514.8 [2M + Na]+. HRMS (ESI): calcd.
for C14H18N2O2 [M
+
H]+ 247.14410; found 247.14405.
C14H18N2O2 (246.30): calcd. C 68.27, H 7.37, N 11.37; found C
68.11, H 7.52, N 11.18.
General Procedure for the Allylation of Aldimines with Allyltrichlo-
rosilane in the Presence of a Chiral Formamide: Allyltrichlorosilane
(0.33 mmol, 1.5 equiv.) was added dropwise to a solution of aldim-
ine (0.22 mmol) and formamide (0.22 mmol, 1 equiv.) in dry
CH2Cl2 (0.44 mL). After stirring at room temperature for 72 h, tri-
ethylamine (0.15 mL) in methanol (0.8 mL) was added to quench
the reaction. The mixture was diluted with CH2Cl2 and water. The
organic layer was separated, dried with anhydrous Na2SO4, filtered
and concentrated under reduced pressure. The crude product was
purified by column chromatography on silica gel (CH2Cl2) to give
the pure product.
Compound 5: This compound was prepared from N-formyl--pro-
line and (S)-phenylethylamine by the same procedure as described
above for 2 to give 5 as a white solid in 93% yield. [α]2D0 = +89.8
1
(c = 1, CHCl3). H NMR (300 MHz, CDCl3, cis and trans forms):
δ = 8.21 and 8.18(2ϫs, 1 H, CHO), 7.46 and 6.76 (2ϫd, J = 7.2
and 7.5 Hz, 1 H, NH), 7.29–7.17 (m, 5 H), 5.09 and 4.99 (2ϫquin-
tets, J = 7.5 and 7.1 Hz, 1 H), 4.48 and 4.29 (2ϫdd, J = 7.7 and
4.1 Hz; J = 7.7 and 3.8 Hz, 1 H), 3.52–3.39 (m, 2 H), 2.46–2.40
and 2.15–2.07 (m, 1 H), 1.97–1.72 (m, 3 H), 1.43 and 1.41 (2ϫd,
J = 7.2 and 6.6 Hz, 3 H, Me) ppm. 13C NMR (75.5 MHz, CDCl3,
major isomer): δ = 169.20, 162.21, 143.36, 128.44, 126.92, 125.73,
57.79, 49.02, 46.81, 26.82, 24.01, 22.55 ppm. 13C NMR (75.5 MHz,
CDCl3, minor isomer): δ = 170.40, 162.10, 142.75, 128.60, 127.33,
9a: 1H NMR (300 MHz, CDCl3): δ = 7.27 (d, J = 8.9 Hz, 2 H),
6.85 (d, J = 8.9 Hz, 2 H), 6.69–6.67 (m, 2 H), 6.58–6.53 (m, 1 H),
6.41 (d, J = 7.2 Hz, 1 H), 5.84–5.70 (m, 1 H), 5.21–5.10 (m, 2 H),
4.32 (t, J = 6.5 Hz, 1 H), 3.77 (s, 3 H), 2.59–2.53 (m, 2 H) ppm.
13C NMR (75.5 MHz, CDCl3): δ = 158.38, 143.65, 135.96, 135.50,
125.84, 60.69, 48.74, 44.22, 30.31, 22.76, 21.45 ppm. IR (KBr): ν =
˜
3290, 3062, 2968, 2927, 2916, 2893, 2866, 2851, 2782, 2656, 2599,
Eur. J. Org. Chem. 2007, 2623–2629
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2627